We got a massive sell off this morning for no real good reason and yet, we're making our way back to where we began. Nice! We are ready to rip past .20 cents and soar somewhere between .25 and .30 cents tomorrow.
Yeah, I compare today's action with some "cleanses" I have done. You feel so much better afterward! We'll be stronger as a result of the sell off and recovery.
No one likes corrections, but it's nature's way. We are in such a better position to have a nice run the remainder of the week! We'll go over .25 cents in a more stable way because of this morning's purge. Hold on folks!
Exactly! Jegfsu, I think this answers your question. The communication problem is the result of their purchase of version 2. That changed their plans for testing, but they didn't communicate it to shareholders very well. I was really upset when they didn't release what I expected in Copenhagen but after a couple of days I was able to get to the bottom of it. We're good. Version 2 is better and more accurate than version 1. We'll see that tomorrow. We'll continue to see more in the coming weeks and months leading up to commercialization. I am so glad we had this massive sell off today instead of on Friday. This reminds me of some "cleanses" I've done in the past. AMBS has been going up so fast, it needed to lose some of the garbage new shareholders we've accumulated recently. (Short term traders) We'll go up stronger tomorrow as a result of today's cleanse.
Initially, AMBS was going to do a "larger test" (For the Analytical Performance Thing) in Q2 of 2014. It was going to be in the 150 patient to 200 patient range. But, they purchase Lympro version 2 two or three months ago and that changed their plans. Instead of going ahead with the "large test" using version 1, they decided to do a "bridge test" with 72 patients that compares version 2 with version 1. They will be reporting tomorrow on a portion of that "bridge test." Gerald told us in his blog after Copenhagen that they would be doing the "large test" once they are in the CLIA partner's lab. He even mentioned that Beckton Dickenson had passed off testing to our target CLIA partner several times in the past...successfully. I think all of this has not been communicated well by the company and is the cause for shareholder confusion. But I think I understand the switching of the tests and I am comfortable that LymPro is on track and the data is "real and it is spectacular," as Jackie Chiles would say.
The following was just posted on I-hub by JP:
"just had a quick email dialogue w/GC
tomorrow will still be Epic
final test data still execptional and will be released shortly
watch out when that happens...."
I honestly believe this correction is healthy. By falling so low today and losing the profit takers and weak hands, it will make our move up to .25 cents more stable tomorrow.
I guess after Copenhagen when Gerald said we would have the "top line data" from the Bridge Test that you didn't understand what that meant? It meant the Bridge Test would not be complete by the 31st but they would present a summary of what had been completed. The reason for all of this is because we bought LymPro version 2, which is better than version 1. The large 160 man test that AMBS was going to do with LymPro version 1 in Q2 2014 was delayed because we bought version 2. We decided to do a "bridge test" to compare version 1 with 2. A portion of that test will be presented tomorrow. It will be fantastic! In Gerald's blog after Copenhagen he said that once we are in our CLIA partner's lab we will do the larger 160 man test to get validated in the lab. We're on target to commercialize and up list this year. Version 2 changed the order of some of the test, but has improved the blood test results. We're good. I figured all this out after the Copenhagen thing. Some people on the mb participated with me in getting to the bottom of it, but many longs just thought my probing questions were unnecessary worry. Well, maybe so, but I'm feeling pretty good this morning. I bought a few more shares at .171 cents and am confident we'll be singing Gerald's praises tomorrow.
Ah, but going up higher and higher each week is fine! If you don't think we won't be much higher tomorrow, you're not very wise.
Guys, this is a small Bio-tech stock. We have break through science. We will go up with breathtaking velocity, and we will correct with gut checking severity. That is how these kind of stock work. Don't you realize that when we zoom up to $1.50 cents one day, that we'll probably re-test $1.00 at some point, on the way to hitting $1.80? Get used to it! This is an exciting roller coaster ride. If you believe in the science and the assembling AMBS team, you'll get through these dips. For those of you who are sick to your stomach...just trust me. We'll be back above .20 cents tomorrow. When we do recover tomorrow, let this be a lesson to you. Don't panic, we're fine. We're more than fine, we're doing great!!
We really did go up to .1935 cents quickly! Today's retrace downward probably got rid of a lot of traders, weak hands, and profit takers. I'm sure we're going to experience a nice sling shot back to where we were and higher. The LymPro "bridge" data that will be presented tomorrow will be outstanding! It will be a taste of more good news to follow. Today's reaction will soon be forgotten. This is actually a healthy thing for the stock that we retraced today. When we go up and above .20 cents tomorrow and approach .25 cents, there will be less fear about falling all the way back down below .16 cents. We've done that today! All the diagnostic experts Gerald has brought on this past year are all still on board. The LymPro data is outstanding. This stock price action today is a blip! We'll be well above .20 cents tomorrow, you can count on it!!!
To be precise as to what portion of the entire test would be reported on. Instead of all 72 patients from 3 sites they are reporting on 44 from one. Does that clear it up for you? Two weeks ago Gerald referred to "top line data" from the Bridge Test being reported on. That indicated to me that the Bridge Test wouldn't be totally completed by the 31st. This PR clarifies that.
He did tell us two weeks ago that only the "top line data" would be presented on the 31st. That meant that the entire test results would not be completed by the 31st. We're getting a significant portion, though.
Gerald told us after the Copenhagen Conference that he would be reporting the "top line" data from the "Bridge Study" on the 31st. That means a partial summary of the test, not the complete results. He knew back then that the entire test results would not be done. We're going to get a part of the results tomorrow. People are making too big a deal out of the wording here. They are just clarifying that the entire results are not complete yet. I didn't think they would be, that's why he told us we'd get the "top line data." I hope the stock dips a bit because I am buying a few more shares today.
It's hard to go to sleep. I can't wait for the cat to wake me up each morning at 5:30 am! I go to the toilet, feed the cat, turn on my Ameritrade software and the fun begins! It's a great world!
bif: Google "ROTH yearly contributions" and it will tell you how much a 67 year old can contribute. I think $6,000 is right. Yes, if you put in $6,000 and it goes up 40 times over the next few years, the $240,000 that would come to would be completely tax-free when you pull it out. I think a ROTH is a smart thing!
narrowmoor: I don't know where to start. There are a group of us longs that have been in the stock over a year or two and have done so much due diligence we could fill a library with it. I do a lot of summarizing of AMBS in my posts. Try going back and reading my past posts and that might help. Go to the AMBS website. Most of us believe the pps will be north of .50 cents by November when we will most likely up list. It's entirely possible we could be over $1.00 by then if enough catalysts hit in time. So to be averaging in new shares each day is good for the next month or so at least.
Nope. You pay less taxes if you hold the shares over a year. For those of you in your 50s you might want to transfer shares into your ROTH. All the growth can be accessed after age 59.5 tax-free.